Halaman 8 - Dokter Terbaik di Espanha — Dapatkan Konsultasi Online

With a Degree in Medicine obtained at the Granada University, he is the author of three books entitled: “Electrocardiography for Residents”, “Urgencies Manual” and “Protocol for Infectious Endocarditis”.

Additionally, he has written over 80 publications for conferences, including price-awarded “Ischaemic Cardiopathy in Women” and “Refractory Angina”.

Dr Said Barakat is considered to be a reference in cardiology in the Andalusian region. Additionally, he has been designated as the Head of the Diplomatic Corps and the Community of Saudi Arabia in health matters by the Embassy of said country in Malaga.

Professional Experience

Over 15-years' experience

• Head of the Unit and Head of the Clinical and Supplementary Tests
• Area of Quirón Marbella Hospital (2003 - currently).
• Head of the Diplomatic Corps and the Saudi Arabia Community appointed by the Embassy of said country in Malaga.
• Head of the Neumopac (Functional Respiratory Tests) Unit.
• Head of the Nuclear Cardiology Unit of the Tanit Institute in Malaga.
• University Degree in Medicine at the Granada University.
• Resident Doctor in Cardiology at the Carlos Haya Hospital in Malaga.

The Cardiology Unit of Quirónsalud Marbella Hospital is made up of a medical team with large experience in the diagnosis and treatment of heart diseases, as well as employing the most advanced technologies, both in the clinical area and in the area of haemodynamics and arrhythmia.

Diseases, treatments and techniques:

Clinical cardiology

- Adult and children cardiology consultation with the performance of supplementary tests, all within one appointment.

- Specific consultations for arrhythmia

- Paedriatic cardiology

- Colour Doppler echocardiography and stress echocardiography

- Stress test

- 24-hour and long-term Holter EKG

- CT coronary angiogram

- Cardiac magnetic resonance imaging (MRI)

- Tilt table testing

- Cardiac rehabilitation

Cardiac haemodynamics

- Diagnostic cardiac catheterisation and percutaneous treatment of ischaemic heart disease with angioplasty and stent implant

- Myocardial infarction percutaneous treatment programme

- Transcatheter aortic valve implantation (TAVI)

- Percutaneous repair of the mitral valve (Mitral clip)

- Percutaneous closure of interatrial communication

- Percutaneous closure of left atrial appendage

Arrhythmia Unit  

- Diagnostic electrophysiological study  

- Catheter ablation

- Cryoablation of atrial fibrillation

- Ablation using a complex arrhythmic substrate navigator

- Pacemaker implantation  

- Automatic endovenous and subcutaneous implantable defibrillator

Cardiac surgery  

- Surgery with and without extracorporeal circulation

- Minimally-invasive surgery with an early extubation

- Repair of mitral and aortic valves

An expert in microbial resistance and optimisation of the use of antimicrobials, he leads the Infectious Disease Unit of this hospital in Malaga.

Dr Javier Moreno Izarra is habitually involved in national and international scientific events. At the same time, he gives presentations that are specially focused on infectious disease in the area of antimicrobial resistance and in medical forums dedicated to the development of programs to optimise the use of antimicrobials.

Professional Experience:

• Head of the Internal Medicine Unit. Quirónsalud Marbella Hospital

• Head of the Internal Medicine Unit. Quirón Campo de Gibraltar Hospital

• Specialist of the Internal Medicine Unit. Alto Guadalquivir Hospital

• Specialist of the Internal Medicine Unit. Andújar Hospital

• Medical Coordination of the A&E Unit and Hospitalisation. High- resolution Hospital in Puente Genil

• Specialist of the Internal Medicine Unit. Costa del Sol Hospital

A member of:

• Spanish Society of Internal Medicine

• Spanish Society of Infectious Disease and Clinical Microbiology

• Spanish Society of Palliative Care

The Internal Medicine speciality is a branch of medicine that focuses on the diagnosis, treatment and prevention of diseases and conditions of adult patients. Internists of the Quirónsalud Marbella Hospital are experts in the comprehensive health care of their patients as they manage a broad range of medical conditions. The team of specialists of our Marbella hospital stands out for its comp rehensive approach and deep knowledge and skills relating to chronic disease. Their objective is to provide a high-quality medical service while guiding the patient and coordinating the actions against their diseases in close cooperation with the other specialists, if necessary, in order to obtain an adequate diagnosis and treatment. One fundamental part of the work of an internist is the management of chronical diseases such as diabetes, hypertension, heart and lung disease, amongst others.

These conditions often require follow-ups and adjustments to the treatment throughout time.

The Internal Medicine team does not only focus on the treatment of diseases, but also on their prevention. Internists work with their patients to identify the risk factors and promote healthy habits. 

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.

Education and Training

Doctor of Medicine, Cum Laude, University of Navarra (1991)

Medical Degree, University of Navarra (1979–1985), Graduated with Honors

Board-Certified Specialist in Medical Oncology, via Spanish MIR system, Clínica Universidad de Navarra (1986–1989)

Advanced Fellowship in Immunotherapy, Cleveland Clinic Foundation, USA

Professional Experience

Head of Medical Oncology (1993–2000) and Director of the Cancer Institute (2000–2002), General Hospital of Catalonia

Director of Hematopoietic Progenitor Transplant Program, General Hospital of Catalonia (1993–2002), accredited by the Catalonian Health Department

Senior Specialist in Oncology, Quirónsalud Torrevieja (since 2002)

Clinical Innovations & Special Programs

Personalized Cancer Therapy using RNA microarrays and pharmacogenomics

Autologous Bone Marrow Transplants and High-Dose Chemotherapy

High-Dose Interleukin-2 Therapy via intravenous bolus for solid tumors

Personalized Cellular Anti-Tumor Vaccines

Hyperthermic Isolated Limb Perfusion with TNF and melphalan

Intra-arterial and Intraoperative Chemotherapy (HIPEC) for advanced cancers

Research & Academic Contributions

Author of 120+ scientific papers and conference presentations

Active contributor to the development of novel cancer immunotherapies and drug personalization strategies

Memberships

AACR – American Association for Cancer Research

ASCO – American Society of Clinical Oncology

ASH – American Society of Hematology

Specialties

-General and Digestive Surgery

-Laparoscopic Surgery (Minimally Invasive Techniques)

-Surgical Oncology

-HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

-Colorectal, Gastric, and Peritoneal Cancer Surgery

Current Position

Senior Surgeon, Department of General and Digestive Surgery

Hospital Quirónsalud Torrevieja, Spain

Clinical Expertise

Minimally invasive cancer surgery with laparoscopic and robotic techniques

Cytoreductive surgery with HIPEC for peritoneal carcinomatosis

Colorectal cancer, gastric cancer, and complex abdominal surgeries

Multidisciplinary treatment planning for gastrointestinal malignancies

Academic & Research Contributions

Author of numerous peer-reviewed publications and book chapters in surgical oncology

Frequent speaker at international congresses on advanced surgical oncology and HIPEC

Actively involved in clinical research and surgical training programs

Professional Recognition

Widely regarded as a reference in Spain and internationally for HIPEC and advanced laparoscopic cancer surgery

Mentor to upcoming surgeons in the field of minimally invasive oncologic surgery

Research and Publications:

Extensive Scholarly Work: Authored and co-authored over 48 publications focusing on surgical oncology, hepatobiliary surgery, and innovative cancer treatments. His research has garnered over 1,100 citations, reflecting significant contributions to the medical community. ​

Professional Affiliations:

Academic Roles: Serves as an Associate Professor in the Department of Health Sciences at Saint Anthony Catholic University in Murcia, Spain, since January 2014

His extensive training includes qualifications that award him the specialisation in endovascular techniques relating to angiology, such as the certification to manage vascular laboratories and X- ray facilities with medical purposes granted by the Medical Physics Spanish Association, as well as numerous training positions in national and international medical centres and hospitals in France, the UK and the USA.

Dr Gallardo Pedrajas combines his medical practice with his teaching position as an Assistant in the Surgery Studies of the Malaga University and the European Society of Vascular Surgery (ESVS). He is also very active as a scientific researcher and proponent, with numerous research papers and projects being published in scientific journals of international reputation, and has been involved in more than 100 medical lectures and communications within his specialisation.

Professional experience

• Medical Residency in Angiology and Vascular Surgery, A Coruña University Hospital.( 2007-12).

• Consultant Doctor in Medicine, Angiology and Vascular Surgery, Santiago de Compostela University Hospital and A Coruña San Rafael Hospital (2012-15).

• Consultant Doctor in Medicine, Angiology and Vascular Surgery, Quirónsalud Marbella-Malaga Hospitals (2015-22).

• Head of the Angiology and Vascular Surgery Unit, Quirónsalud Marbella Hospital (2022- currently).

Member of Scientific Associations:

He is a member of the Board of Directors of the following:

American Cardiology JACC Journal and a revisor of the Board of Editors of JVET.

Secretary of the Andalusian Vascular Society and a member of the Committee of Directors of the Spanish Vascular Surgery Society (SEACV, in its Spanish abbreviation).

European Society of Vascular Surgery. A Professor of the ESVS Academy and Convenor for aorta and vascular access.

Vascular Surgery Quirónsalud Marbella Hospital has a team of specialists in Angiology and Vascular Surgery, supported by a nursing team with large experience and knowledge in the diagnosis and treatment of vascular diseases and their potential complications. This healthcare multidisciplinary approach helps us offer premium quality medical assistance to our patients.

The Angiology and Vascular Surgery Unit stands out for the implementation and development of technologically-advanced techniques in the comprehensive treatment of artery and venous diseases, with special interest in minimally- invasive endovascular treatments, not only to solve varicose vein issues, but also aneurysm and obstructive artery disease.

Our healthcare professionals deal with the prophylaxis, diagnosis and treatment of vascular diseases such as artery, venous and lymphatic disease. Each patient is taken through a process of individualised rapid and coordinated assessment.

Diseases, treatments, techniques and multidisciplinary units

Artery disease: endovascular or surgical treatment of aneurism or supra-aortic trunks occlusive disease; visceral, renal, aortic and limb arteries

• Venous disease: haemodynamic surgery and sclerotherapy of varicose veins
• Treatment of venous thromboembolism
• Lymphatic disease: diagnosis and treatment
• Artery-vein malformation: diagnosis and treatment
• Our hospital is a reference in the salvage of limbs (diabetic foot and critical limb ischaemia).

Dokter adalah seorang dokter mata anak dengan pengalaman lebih dari 20 tahun, yang berspesialisasi dalam katarak bawaan dan bedah segmen anterior pediatrik. Sejak 1996, dokter telah menjadi spesialis dalam oftalmologi di Rumah Sakit Anak Sant Joan De Déu-Barcelona.<\/p>

Dokter lulus dari Universitas Barcelona dengan gelar dalam bidang kedokteran umum dan bedah pada tahun 1991 dan menyelesaikan spesialisasi dalam oftalmologi di Rumah Sakit Klinik Barcelona pada tahun 1996. Sejak 2013, dokter terlibat dalam pengajaran di Rumah Sakit Sant Joan de Déu Barcelona.<\/p>

Dokter adalah anggota dari Masyarakat Oftalmologi Katalan, Masyarakat Strabologi Spanyol, dan Masyarakat Oftalmologi Pediatrik Eropa.<\/p>

Dr. Jose Hinojosa Mena-Bernal is a Spanish pediatric neurosurgeon. He specializes in neuro-oncology, neuroendoscopy, maxillofacial, and minimally invasive surgery. He leads the Neurosurgery Department at Sant Joan De Déu Children’s Hospital. Dr. Hinojosa has also held leadership positions at other major hospitals in Spain.

He has written 93 scientific papers. Dr. Hinojosa works as an editor and reviewer for leading neurosurgical journals. He is President of the Spanish Society of Pediatric Neurosurgery. He is also an active member of international groups such as ISPN and EANS. His roles show his strong reputation and influence in pediatric neurosurgery.

Pediatric orthopedist-traumatologist, specializes in surgical oncology

15 years of experience

• 
  
• He passed specialization in orthopedic surgery and traumatology at the Children's Research Hospital of St. Jude in Memphis, USA (2007-2008).
• Dr. Thorner Rubins currently teaches at the University of Barcelona.
• Нe is the head of the Department of Orthopedics and Traumatology at the Hospital Sant Joan de Déu in Barcelona.

Dokter adalah seorang dokter mata anak-anak dengan spesialisasi dalam pengobatan retinoblastoma. Dengan pengalaman luas dalam perawatan mata anak, dokter fokus pada diagnosis dan pengelolaan kanker mata langka ini, menggunakan teknik canggih untuk meningkatkan hasil pasien. Dokter berkomitmen untuk penelitian dan inovasi di bidang ini, berkontribusi pada kemajuan dalam protokol pengobatan dan standar perawatan pasien.<\/p>

Dokter adalah seorang epileptolog anak dengan pengalaman 30 tahun, yang mengkhususkan diri dalam pengobatan medis dan bedah epilepsi masa kanak-kanak, gangguan perkembangan kognitif, dan regulasi emosional dalam bentuk fokal penyakit.<\/p>

Saat ini, dokter mengoordinasikan Program Epilepsi di Rumah Sakit Anak Sant Joan de Déu di Barcelona dan memimpin Unit Epilepsi, Gangguan Tidur, dan Neurofisiologi Pediatrik di Rumah Sakit Universitas Lyon.<\/p>

Terlibat dalam penelitian klinis, dokter berfokus pada pengobatan obat dan bedah epilepsi, fitur genetik epilepsi pada anak-anak, dan gangguan otak yang terkait dengan epilepsi fokal.<\/p>

Dokter bertugas sebagai dokter staf di Grup Epilepsi di Departemen Neurologi Anak, Rumah Sakit Sant Joan de Déu.<\/p>

Selain itu, dokter adalah Asisten Penelitian Klinis di Departemen Epilepsi, Tidur, dan Penelitian Neurofungsional pada Anak, berkontribusi pada kemajuan dalam neurologi pediatrik.<\/p>

Dokter adalah seorang onkosurgeon dengan pengalaman 25 tahun, yang mengkhususkan diri dalam pengobatan kanker rektum dan kolon, bedah bariatrik, dan pengobatan kanker esofagus.<\/p>

Dengan lebih dari 15.000 prosedur bedah yang dilakukan, dokter melakukan lebih dari 1.000 operasi invasif minimal setiap tahun, menggunakan teknik laparoskopi dan robotik.<\/p>

Sebagai anggota masyarakat medis internasional, dokter adalah presiden Asosiasi Ahli Bedah-Endoskopis di Eropa dan memberikan kuliah tentang teknik bedah lanjutan dan laparoskopi.<\/p>

Dikenal sebagai pelopor dalam bedah gastrointestinal, dokter adalah yang pertama melakukan prosedur terobosan seperti pengangkatan kantong empedu melalui mulut dan eksisi mesorektal total transanal pertama (TaTME).<\/p>

Dokter adalah seorang gastroenterolog dengan pengalaman lebih dari 35 tahun, yang berspesialisasi dalam penelitian gastrointestinal, gangguan usus, motilitas usus, sensitivitas visceral, dan dinamika gas usus.<\/p>

Lulus dari Universitas Valladolid di Spanyol pada tahun 1977, dan menyelesaikan residensi dalam bedah umum di Rumah Sakit Universitas San Carlos di Madrid. Lebih lanjut mengasah keahlian dengan beasiswa tiga tahun di Unit Penelitian Gastrointestinal Mayo Clinic.<\/p>

Fokus pada masalah gastrointestinal fungsional, dokter menerima Penghargaan Janssen untuk Penelitian Klinis dalam Penyakit Pencernaan pada tahun 1999 dan menjabat sebagai Presiden Masyarakat Eropa untuk Neurogastroenterologi dan Motilitas.<\/p>

Dokter ini telah memfokuskan penelitian pada sindrom neurologis paraneoplastik, memimpin panel yang menetapkan kriteria diagnostik. Karyanya mengkonfirmasi hipotesis imun yang menghubungkan tumor dengan disfungsi neurologis autoimun, dengan antibodi yang diidentifikasi olehnya sekarang menjadi penting untuk diagnosis.<\/p>

Secara klinis, dokter ini mengkhususkan diri dalam mendiagnosis dan mengelola glioma, limfoma otak primer, dan neurotoksisitas terkait pengobatan kanker. Minat terbaru termasuk komplikasi neurologis dari inhibitor pos pemeriksaan imun dan transplantasi sel induk hematopoietik.<\/p>

Dia memiliki gelar MD dan PhD dari Universitat Autónoma de Barcelona, menyelesaikan residensi neurologi di Barcelona, dan fellowship neuro-onkologi di Memorial Sloan-Kettering Cancer Center.<\/p>

Dokter adalah seorang ilmuwan klinis dengan keahlian dalam penerapan klinis dari temuan laboratorium pada kanker payudara, berfokus pada ekspresi gen dan subtipe molekuler. Dokter merancang dan memimpin uji klinis untuk obat dan pendekatan baru di SOLTI, sebuah kelompok koperasi kanker payudara Spanyol.<\/p>

Setelah lulus dengan gelar MD dari Universitas Barcelona pada tahun 2003, dokter menyelesaikan fellowship onkologi medis di Institut Onkologi Vall d'Hebron dan penelitian pascadoktoral di Universitas Carolina Utara.<\/p>

Saat ini, dokter memimpin Kelompok Genomik Translasional dan Terapi Bertarget pada Tumor Padat di IDIBAPS dan merupakan Presiden Dewan Direksi SOLTI. Dokter telah ikut mendirikan Reveal Genomics dan memegang tiga paten.<\/p>

Dengan lebih dari 160 publikasi dan H-Index 51, dokter telah dikutip 13.479 kali dan telah menyampaikan 95 komunikasi secara internasional.<\/p>

Dokter ini mengkhususkan diri dalam pengobatan kanker payudara dan endokrin, dengan fokus pada mengatasi resistensi terhadap terapi hormon selama penyakit adjuvan dan metastatik. Secara aktif terlibat dalam studi fase 1, 2, dan 3 untuk kanker payudara dan melanoma, dokter ini telah berkontribusi pada persetujuan obat baru, termasuk inhibitor cdk4/6 seperti palbociclib dan ribociclib untuk kanker payudara metastatik, dan perawatan imunoterapi seperti Pembrolizumab, Nivolumab, dan Ipilimumab untuk melanoma. Dokter ini adalah anggota dari Unit Kanker Payudara dan Unit Melanoma di Rumah Sakit Universitas Vall d’Hebron dan Institut Onkologi Vall d’Hebron.<\/p>

Dokter ini berspesialisasi dalam angiogenesis, mekanisme perbaikan DNA, dan imunologi, berperan sebagai Peneliti Utama dalam uji klinis untuk kanker ovarium, serviks, dan endometrium. Dengan gelar dalam bidang Kedokteran dan Bedah dari Universitas Complutense Madrid dan gelar PhD dari Universidad Autonoma de Barcelona, dokter ini telah menerbitkan lebih dari 100 karya dan presentasi. Dokter ini adalah Co-Ketua Grup GEICO dan anggota fakultas untuk Gyn-Track di European Society of Medical Oncology. Selain itu, dokter ini adalah anggota aktif ASCO, ESMO, dan SEOM.<\/p>

Dokter ini mengkhususkan diri dalam limfoma dan leukemia limfositik kronis, memimpin inovasi dalam analisis dan pengobatan penyakit hematologi. Dikenal secara global atas keahliannya dalam Leukemia Limfositik Kronis (CLL), dokter ini melakukan penelitian klinis dan dasar yang signifikan, berfokus pada patogenesis molekuler dan pendekatan terapeutik baru.<\/p>

Saat ini terlibat dalam lebih dari 80 studi dari fase 1 hingga fase 3, dokter ini berkontribusi pada pengembangan obat dan perawatan baru. Sebagai Kepala Hematologi di IOB Institute of Oncology dan Kepala Departemen Hematologi di Vall d’Hebron University Hospital, dokter ini telah menerbitkan lebih dari 100 artikel di jurnal bergengsi.<\/p>